Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 August 2020 | Story Xolisa Mnukwa | Photo Pixabay

Mental health is a crucial component for a healthy and happy life, as it directly affects how we think, feel, and behave. Mental health also determines how we manage stress, cope with challenges, relate to others, and contribute to our community.  

As noted in the University of the Free State (UFS) #WellbeingWarriors campaign, heightened negative emotions during the COVID-19 pandemic are normal. You might experience feelings of anxiety, fear, sadness, helplessness, anger, and confusion. Your thoughts can also increase negative emotions, but thoughts are not always reality. Therefore, it is best to educate yourself.

According to Dr Melissa Barnaschone – UFS Director for Student Counselling and Development (SCD), the South African Depression and Anxiety Group (SADAG) will establish and enhance the mental-health support services offered by SCD and Careways as from 1 September 2020 in the following ways: 

- SADAG will extend SCD services by offering a dedicated UFS student mental health careline, which is free and accessible 24/7 to all UFS students. This will ensure that a constant means of mental-health support is available to UFS students. 

- Careways will serve as an extension of the emergency services offered by SCD.

Dr Barnaschone further explained that SADAG is working closely with the university to assist identified students, who will benefit from longer-term counselling offered by the SCD in order to continue with their therapeutic process. SADAG will also offer further support to students while they wait for their appointments with SCD.

This helpline will provide containment, crisis intervention, and support, as well as referrals to mental-health professionals and other psychosocial resources for all students on all the UFS campuses. 
students also have the option to contact SADAG by email or SMS for counselling assistance. 

Counselling for both the SADAG and Careways services will be available in the various South African languages.

Dr Barnaschone reiterated that the SCD will continue with all the services and resources currently offered by the department, and that these additional counselling services will serve as an extension of the SCD, assisting them with patient capacity and reducing the waiting period for students to receive adequate mental-health support and counselling. 

“As we are all navigating the uncertainties and changes that are taking place within our environments, it is vital to remember that we are all human and that we are feeling overwhelmed, stressed, or anxious. We need to keep reminding ourselves and each other that this is not a hopeless situation, and when we feel that we need help, all we need to do is ask for it. We are all here to support each other,” encouraged Dr Barnaschone.



News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept